Dr. Beth Parker, PhD, Speaking at CHIP Thursday, September 12, 2013
On Thursday, September 12 2013, from 12:30 – 1:30 pm, we begin the fall, 2013 lecture series with a talk by Beth Parker, Ph.D., Assistant Professor, Department of Health Sciences and Nursing, University of Hartford, about “Are Marathons Dangerous? Updates and Insights from the 2010-2012 Boston Marathon Studies.” This is co-sponsored by the Office of the Vice President for Research.
The lecture will be in Video Conference Room 204 on the second floor of Ryan at 2006 Hillside Road at the University of Connecticut in Storrs. For a map of the area, look at http://www.chip.uconn.edu/about/directions-to-chip/. It is co-sponsored by the UConn Office of the Vice President for Research.
You can also view this talk streamed live during or after the lecture at the following link: http://www.chip.uconn.edu/lecture-9-12-13.
Dr. Beth Parker is an Assistant Professor of Health Sciences and the Director of the Center for Health, Care and Well-Being in the Institute for Translational Research at University of Hartford as well as the Director of Exercise Physiology Research at Hartford Hospital. Her research focuses on age and sex differences in vascular function and cardiovascular responses to exercise. She currently has research support to investigate the effects of factors such as smoking, testicular cancer; exercise and aging on vascular function. She also is a principal or co-investigator on several NIH-funded projects involving the pleiotropic effects of statin therapy (cholesterol-lowering drugs) in humans. These projects include investigation of the direct effects of statins on skeletal muscle strength and aerobic performance, the effects of Coenzyme Q10 supplementation on skeletal muscle side effects, and cognitive side effects of statins assessed with functional magnetic resonance imaging.
An avid runner herself, Parker has conducted recent studies at the Boston Marathon to determine the effects of sustained endurance exercise on blood clot risk, markers of cardiovascular injury and stress, and the effects of cholesterol-lowering drugs on these biomarkers. She also maintains a blog (http://uheart.wordpress.com) dedicated to updates and insights on health and wellness.